Food/Warning Letter·FDA Warning Letters

Warning Letter — Boba Factory Inc

MediumPublished Jun 2, 2026· AI-analyzed Jun 2, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

The FDA issued a Warning Letter to Boba Factory Inc. following an inspection by the Office of Inspections and Investigations.

Who it affects

This affects Boba Factory Inc., its manufacturing personnel, and quality management stakeholders.

Why it matters

The issuance of a Warning Letter by the Office of Inspections and Investigations indicates that the FDA identified significant regulatory non-compliance during its facility tour. Failure to address these observations may lead to further enforcement actions, such as seizure or injunction. While the source does not list specific violations, such letters typically stem from deviations in manufacturing practices or food safety protocols.

Practical takeaway

Regulatory and Quality teams should review current manufacturing practices against food safety standards and prepare for potential follow-up inspections. Ensure all documentation and facility operations are aligned with applicable FDA compliance requirements.

FDA source material

FDA Warning Letter issued to: Boba Factory Inc. 04/22/2026 — Office of Inspections and Investigations. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/boba-factory-inc-728438-04222026

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.